Anton Gueth, Director at ANTARES PHARMA, INC. (AIS), sold 243,769 shares at $2.85 ($703K) on 2012-05-30, disclosed to the SEC on 2012-05-31.
Open-market sale of $703k AIS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.90 | 603 | $2K | 0.2% |
| 2 | $2.90 | 5,345 | $16K | 2.2% |
| 3 | $2.90 | 9,655 | $28K | 4.0% |
| 4 | $2.90 | 9,865 | $29K | 4.1% |
| 5 | $2.90 | 10,621 | $31K | 4.4% |
| 6 | $2.90 | 22,067 |
| $64K |
| 9.1% |
| 7 | $2.90 | 30,956 | $90K | 12.8% |
| 8 | $2.90 | 31,955 | $93K | 13.2% |
| 9 | $2.90 | 35,202 | $102K | 14.5% |
| 10 | $2.85 | 87,500 | $249K | 35.5% |
| Total | $2.88 avg | 243,769 | $703K | 100% |
| Filing → |
| ATRS | BUY | 2014-08-13 | $10K | — | Filing → |
| ATRS | SELL | 2013-09-05 | $111K | — | Filing → |
| ATRS | SELL | 2013-08-05 | $110K | — | Filing → |